Matthew Philip Goetz, MD

  • 9485 Citations
  • 46 Scopus h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In : npj Breast Cancer. 6, 1, 15.

Research output: Contribution to journalReview article

Open Access
2 Scopus citations

Breast cancer version 2.2015: Clinical practice guidelines in oncology

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M., Goldstein, L. J., Hudis, C. A., Isakoff, S. J., Marcom, P. K., Mayer, I. A., McCormick, B., Moran, M., Patel, S. A., Pierce, L. J. & 11 others, Reed, E. C., Salerno, K. E., Schwartzberg, L. S., Smith, K. L., Smith, M. L., Soliman, H., Somlo, G., Telli, M., Ward, J. H., Shead, D. A. & Kumar, R., Apr 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 4, p. 448-475 28 p.

Research output: Contribution to journalReview article

Open Access
128 Scopus citations

Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)

Kittaneh, M., Badve, S., Caldera, H., Coleman, R., Goetz, M. P., Mahtani, R., Mamounas, E., Kalinsky, K., Lower, E., Pegram, M., Press, M. F., Rugo, H. S., Schwartzberg, L., Traina, T. & Vogel, C., Jun 2020, In : Clinical breast cancer. 20, 3, p. 183-193 11 p.

Research output: Contribution to journalReview article

Open Access
2 Scopus citations

Coprescription of tamoxifen and medications that inhibit CYP2D6

Sideras, K., Ingle, J. N., Ames, M. M., Loprinzi, C. L., Mrazek, D. P., Black, J. L., Weinshilboum, R. M., Hawse, J. R., Spelsberg, T. C. & Goetz, M. P., Jun 1 2010, In : Journal of Clinical Oncology. 28, 16, p. 2768-2776 9 p.

Research output: Contribution to journalReview article

100 Scopus citations

CYP2D6 genotype and tamoxifen: Considerations for proper nonprospective studies

Goetz, M. P. & Ingle, J. N., 2014, In : Clinical pharmacology and therapeutics. 96, 2, p. 141-144 4 p.

Research output: Contribution to journalReview article

10 Scopus citations

Developments in combination chemotheraphy for colorectal cancer

Goetz, M. M. P. & Grothey, A., Aug 2004, In : Expert review of anticancer therapy. 4, 4, p. 627-637 11 p.

Research output: Contribution to journalReview article

9 Scopus citations

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)

Abraham, J., Caldera, H., Coleman, R., Elias, A., Goetz, M. P., Kittaneh, M., Lower, E., Mahtani, R., Terry Mamounas, E., Pegram, M., Rugo, H., Schwartzberg, L., Traina, T. & Vogel, C., May 1 2018, In : Breast Cancer Research and Treatment. 169, 1

Research output: Contribution to journalReview article

3 Scopus citations

Endocrine therapy in 2009: Consideration of the tumor and the host

Goetz, M. P., Ames, M. M., Weinshilboum, R. M. & Ingle, J. N., Feb 1 2009, In : Oncology. 23, 2, p. 150-151+154

Research output: Contribution to journalReview article

Image-guided ablation of painful metastatic bone tumors: A new and effective approach to a difficult problem

Callstrom, M. R., Charboneau, J. W., Goetz, M. P., Rubin, J., Atwell, T. D., Farrell, M. A., Welch, T. J. & Maus, T. P., Jan 1 2006, In : Skeletal Radiology. 35, 1, p. 1-15 15 p.

Research output: Contribution to journalReview article

147 Scopus citations

Innovative Strategies: Targeting Subtypes in Metastatic Breast Cancer

Pegram, M. D., Zong, Y., Yam, C., Goetz, M. P. & Moulder, S. L., May 23 2018, In : American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 38, p. 65-77 13 p.

Research output: Contribution to journalReview article

4 Scopus citations

Invasive breast cancer version 1.2016

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M., Goldstein, L. J., Hudis, C. A., Isakoff, S. J., Kelly Marcom, P., Mayer, I. A., McCormick, B., Moran, M., Patel, S. A., Pierce, L. J. & 11 others, Reed, E. C., Salerno, K. E., Schwartzberg, L. S., Smith, K. L., Smith, M. L., Soliman, H., Somlo, G., Telli, M., Ward, J. H., Shead, D. A. & Kumar, R., Mar 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 3, p. 324-354 31 p.

Research output: Contribution to journalReview article

Open Access
204 Scopus citations

Perspectives on triple-negative breast cancer: Current treatment strategies, unmet needs, and potential targets for future therapies

Gupta, G. K., Collier, A. L., Lee, D., Hoefer, R. A., Zheleva, V., van Reesema, L. L. S., Tang-Tan, A. M., Guye, M. L., Chang, D. Z., Winston, J. S., Samli, B., Jansen, R. J., Petricoin, E. F., Goetz, M. P., Bear, H. D. & Tang, A. H., Sep 2020, In : Cancers. 12, 9, p. 1-33 33 p., 2392.

Research output: Contribution to journalReview article

Open Access
1 Scopus citations

Tamoxifen pharmacogenomics: The role of CYP2D6 as a predictor of drug response

Goetz, M. P., Kamal, A. & Ames, M. M., Jan 9 2008, In : Clinical pharmacology and therapeutics. 83, 1, p. 160-166 7 p.

Research output: Contribution to journalReview article

145 Scopus citations

The emerging role of CDK4/6i in HER2-positive breast cancer

O’Sullivan, C. C., Suman, V. J. & Goetz, M. P., 2019, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journalReview article

Open Access

The Hsp90 chaperone complex as a novel target for cancer therapy

Goetz, M. P., Toft, D. O., Ames, M. M. & Erlichman, C., Aug 1 2003, In : Annals of Oncology. 14, 8, p. 1169-1176 8 p.

Research output: Contribution to journalReview article

277 Scopus citations

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice

Gonzalez-Ericsson, P. I., Stovgaard, E. S., Sua, L. F., Reisenbichler, E., Kos, Z., Carter, J. M., Michiels, S., Le Quesne, J., Nielsen, T. O., Lænkholm, A. V., Fox, S. B., Adam, J., Bartlett, J. M. S., Rimm, D. L., Quinn, C., Peeters, D., Dieci, M. V., Vincent-Salomon, A., Cree, I., Hida, A. I. & 55 others, Balko, J. M., Haynes, H. R., Frahm, I., Acosta-Haab, G., Balancin, M., Bellolio, E., Yang, W., Kirtani, P., Sugie, T., Ehinger, A., Castaneda, C. A., Kok, M., McArthur, H., Siziopikou, K., Badve, S., Fineberg, S., Gown, A., Viale, G., Schnitt, S. J., Pruneri, G., Penault-Llorca, F., Hewitt, S., Thompson, E. A., Allison, K. H., Symmans, W. F., Bellizzi, A. M., Brogi, E., Moore, D. A., Larsimont, D., Dillon, D. A., Lazar, A., Lien, H., Goetz, M. P., Broeckx, G., El Bairi, K., Harbeck, N., Cimino-Mathews, A., Sotiriou, C., Adams, S., Liu, S. W., Loibl, S., Chen, I. C., Lakhani, S. R., Juco, J. W., Denkert, C., Blackley, E. F., Demaria, S., Leon-Ferre, R., Gluz, O., Zardavas, D., Emancipator, K., Ely, S., Loi, S., Salgado, R. & Sanders, M., Apr 1 2020, In : Journal of Pathology. 250, 5, p. 667-684 18 p.

Research output: Contribution to journalReview article

Open Access
9 Scopus citations